세계의 자동 인슐린 전달 시스템 시장 : 질환 유형별, 유통별 예측(2025-2030년)

The Automated Insulin Delivery System Market was valued at USD 821.39 million in 2023, expected to reach USD 901.04 million in 2024, and is projected to grow at a CAGR of 9.79%, to USD 1,579.49 million by 2030.

The market for Automated Insulin Delivery Systems (AID) is expanding as technology aids diabetes management by automating insulin delivery. The AID system integrates continuous glucose monitoring (CGM) with insulin pumps and advanced algorithms to optimize insulin dosage. This system is crucial for enhancing the quality of life for individuals with Type 1 and increasingly, Type 2 diabetes, by mitigating manual blood glucose regulation. Its application spans personal use predominantly, but institutional use in clinics is gaining traction. Key growth factors include rising diabetes prevalence, technological advancements in wearable medical devices, and increased healthcare expenditure. The market benefits significantly from technological progress in AI and machine learning, offering novel avenues for precision medicine development. This innovation can bolster personalization in treatment plans, supporting better long-term patient outcomes.

Opportunities lie in emerging markets where diabetes incidences are surging, allowing companies to tap into untapped demographics. Additionally, the integration of AID systems with smartphone technology and IoT platforms represents a transformative opportunity, as it enhances remote patient monitoring and telehealth services. However, challenges such as high cost, regulatory hurdles, cybersecurity concerns, and inadequate awareness about AID systems in developing nations impede growth. Furthermore, the market faces limitations due to restricted insurance coverage and a lack of trained professionals to manage sophisticated diabetes tech.

For innovation, research should focus on enhancing algorithm sophistication for real-time data analytics, improving biocompatibility of wearable devices, and developing cost-effective solutions to widen adoption. Businesses could invest in strategic collaborations for R&D or explore subscription-based models to enhance accessibility. Insight into the market suggests a dynamic and competitive landscape where innovation, partnerships, and regulatory navigation are key to success. As technology continues to evolve, businesses that prioritize patient-centric approaches and invest in robust cybersecurity measures will likely hold a competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Automated Insulin Delivery System Market

The Automated Insulin Delivery System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of diabetes coupled with increasing number of awareness campaigns
  • Availability of improved pipelined and marketed AID systems
  • Developments in AID systems with improved clinical outcomes
• Market Restraints
  • Calibration of a glucose sensor, sensor durability, skin-related issues
• Market Opportunities
  • Up-gradation of existing insulin pumps and new product developmen
  • Increasing R&D activities for the production of innovative insulin delivery systems
• Market Challenges
  • Concerns regarding pump imprecision and sensor inaccuracy or unreliability

Porter's Five Forces: A Strategic Tool for Navigating the Automated Insulin Delivery System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Automated Insulin Delivery System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Automated Insulin Delivery System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Automated Insulin Delivery System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Automated Insulin Delivery System Market

A detailed market share analysis in the Automated Insulin Delivery System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Automated Insulin Delivery System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Automated Insulin Delivery System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Automated Insulin Delivery System Market

A strategic analysis of the Automated Insulin Delivery System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Automated Insulin Delivery System Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Animas Corporation, Becton, Dickinson and Company, Bigfoot Biomedical Inc., Biocon Limited, Dexcom, Inc., Diabeloop S.A., DreaMed Diabetes Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Insulet Corporation, Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., and Tandem Diabetes Care, Inc..

Market Segmentation & Coverage

This research report categorizes the Automated Insulin Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Disease Type, market is studied across Type I Diabetes and Type II Diabetes.
• Based on Distribution, market is studied across Diabetes Clinics, Hospital Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of diabetes coupled with increasing number of awareness campaigns
    • 5.1.1.2. Availability of improved pipelined and marketed AID systems
    • 5.1.1.3. Developments in AID systems with improved clinical outcomes
  • 5.1.2. Restraints
    • 5.1.2.1. Calibration of a glucose sensor, sensor durability, skin-related issues
  • 5.1.3. Opportunities
    • 5.1.3.1. Up-gradation of existing insulin pumps and new product developmen
    • 5.1.3.2. Increasing R&D activities for the production of innovative insulin delivery systems
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns regarding pump imprecision and sensor inaccuracy or unreliability
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Automated Insulin Delivery System Market, by Disease Type

• 6.1. Introduction
• 6.2. Type I Diabetes
• 6.3. Type II Diabetes

7. Automated Insulin Delivery System Market, by Distribution

• 7.1. Introduction
• 7.2. Diabetes Clinics
• 7.3. Hospital Pharmacies
• 7.4. Retail Pharmacies

8. Americas Automated Insulin Delivery System Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Automated Insulin Delivery System Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Automated Insulin Delivery System Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Animas Corporation
• 3. Becton, Dickinson and Company
• 4. Bigfoot Biomedical Inc.
• 5. Biocon Limited
• 6. Dexcom, Inc.
• 7. Diabeloop S.A.
• 8. DreaMed Diabetes Ltd.
• 9. Eli Lilly and Company
• 10. F. Hoffmann-La Roche Ltd.
• 11. Insulet Corporation
• 12. Medtronic PLC
• 13. Novo Nordisk A/S
• 14. Sanofi S.A.
• 15. Tandem Diabetes Care, Inc.